TrialLeukemia2017

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).

A Chanan-Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.